Je Ryong Kim

666 total citations
33 papers, 360 citations indexed

About

Je Ryong Kim is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Je Ryong Kim has authored 33 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 10 papers in Cancer Research and 8 papers in Molecular Biology. Recurrent topics in Je Ryong Kim's work include Cancer Treatment and Pharmacology (10 papers), Breast Cancer Treatment Studies (9 papers) and Breast Lesions and Carcinomas (7 papers). Je Ryong Kim is often cited by papers focused on Cancer Treatment and Pharmacology (10 papers), Breast Cancer Treatment Studies (9 papers) and Breast Lesions and Carcinomas (7 papers). Je Ryong Kim collaborates with scholars based in South Korea, India and United States. Je Ryong Kim's co-authors include Jinsun Lee, Eun Young, Myung Sun Lee, Kwang‐Sun Suh, Phương Thiện Thương, Jun Beom Park, Ji Young Sul, In Sang Song, In‐Sang Song and Jin Sun Lee and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Annals of Surgical Oncology.

In The Last Decade

Je Ryong Kim

27 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Je Ryong Kim South Korea 10 133 130 93 65 58 33 360
Mitsuhiro Mizutani Japan 11 186 1.4× 90 0.7× 265 2.8× 44 0.7× 15 0.3× 24 541
Se-Kyung Lee South Korea 8 148 1.1× 108 0.8× 138 1.5× 22 0.3× 20 0.3× 16 376
Heqing Yi China 12 215 1.6× 154 1.2× 68 0.7× 27 0.4× 59 1.0× 25 418
Syed F. Zafar United States 9 132 1.0× 65 0.5× 111 1.2× 48 0.7× 22 0.4× 18 355
Jyh-Cherng Yu Taiwan 13 295 2.2× 176 1.4× 147 1.6× 109 1.7× 18 0.3× 20 554
Laura Ruíz-Cañas Spain 10 237 1.8× 106 0.8× 103 1.1× 35 0.5× 37 0.6× 22 496
Gianmatteo Pagani Italy 12 147 1.1× 259 2.0× 262 2.8× 105 1.6× 16 0.3× 23 583
Giles Davies United Kingdom 12 110 0.8× 121 0.9× 160 1.7× 134 2.1× 15 0.3× 14 553
Jarosław Szefel Poland 12 123 0.9× 65 0.5× 133 1.4× 37 0.6× 7 0.1× 25 374
Chuanbing Shi China 10 253 1.9× 61 0.5× 65 0.7× 40 0.6× 22 0.4× 22 441

Countries citing papers authored by Je Ryong Kim

Since Specialization
Citations

This map shows the geographic impact of Je Ryong Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Je Ryong Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Je Ryong Kim more than expected).

Fields of papers citing papers by Je Ryong Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Je Ryong Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Je Ryong Kim. The network helps show where Je Ryong Kim may publish in the future.

Co-authorship network of co-authors of Je Ryong Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Je Ryong Kim. A scholar is included among the top collaborators of Je Ryong Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Je Ryong Kim. Je Ryong Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kang, Yea Eun, Jeong‐Hwan Kim, Jong‐Lyul Park, et al.. (2022). Transcriptomic Analysis of Papillary Thyroid Cancer: A Focus on Immune-Subtyping, Oncogenic Fusion, and Recurrence. Clinical and Experimental Otorhinolaryngology. 15(2). 183–193. 10 indexed citations
3.
Won, Ho-Ryun, Eon Ju Jeon, Jae Won Chang, et al.. (2022). Age-Dependent Clinicopathological Characteristics of Patients with T1b Papillary Thyroid Carcinoma: Implications for the Possibility of Active Surveillance. Annals of Surgical Oncology. 30(4). 2246–2253. 4 indexed citations
4.
Lee, Youn Ju, et al.. (2022). The blood level of thioredoxin 1 as a supporting biomarker in the detection of breast cancer. BMC Cancer. 22(1). 12–12. 5 indexed citations
5.
Sohn, Eun Hee, Jin Sun Lee, Mi Sook Jung, & Je Ryong Kim. (2021). A Prospective Study of Taxane-Induced Neuropathy with Breast Cancer: Proper Assessment Tool for Taxane-Induced Neuropathy. South Asian Journal of Cancer. 10(2). 58–63. 2 indexed citations
6.
Kim, Je Ryong, et al.. (2021). The current status of cancer survivorship care and a consideration of appropriate care model in Korea. Korean Journal of Clinical Oncology. 1(1). 0–0.
7.
Kim, Je Ryong, et al.. (2020). The current status of cancer survivorship care and a consideration of appropriate care model in Korea. SHILAP Revista de lepidopterología. 16(2). 110–118. 6 indexed citations
8.
9.
Jung, Mi Sook, Moira Visovatti, Eun Hee Sohn, et al.. (2020). Impact of changes in perceived attentional function on postsurgical health-related quality of life in breast cancer patients awaiting adjuvant treatment. Health and Quality of Life Outcomes. 18(1). 230–230. 8 indexed citations
10.
Woo, Joohyun, Hyungju Kwon, Jong Bin Kim, et al.. (2019). Circulating Plasmacytoid and Myeloid Dendritic Cells in Breast Cancer Patients: A Pilot Study. Journal of Breast Cancer. 22(1). 29–29. 7 indexed citations
11.
12.
Lee, Yu Ran, Myoung Soo Park, Hee Kyoung Joo, et al.. (2018). Therapeutic positioning of secretory acetylated APE1/Ref-1 requirement for suppression of tumor growth in triple-negative breast cancer in vivo. Scientific Reports. 8(1). 8701–8701. 13 indexed citations
13.
Lee, Jinsun, et al.. (2014). A Phase II Trial of Neoadjuvant Chemotherapy with Genexol® (Paclitaxel) and Epirubicin for Locally Advanced Breast Cancer. Journal of Breast Cancer. 17(4). 344–344. 4 indexed citations
14.
Lee, Jinsun, et al.. (2013). Anticancer Activity of Pristimerin in Epidermal Growth Factor Receptor 2-Positive SKBR3 Human Breast Cancer Cells. Biological and Pharmaceutical Bulletin. 36(2). 316–325. 37 indexed citations
15.
Lee, Jinsun, Ji Young Sul, Jun Beom Park, et al.. (2012). Fatty Acid Synthase Inhibition by Amentoflavone Suppresses HER2/neu (erbB2) Oncogene in SKBR3 Human Breast Cancer Cells. Phytotherapy Research. 27(5). 713–720. 63 indexed citations
16.
17.
Kim, Je Ryong, et al.. (2009). 18 F-FDG PET/CT for the Preoperative Diagnosis of Papillary Thyroid Microcarcinoma: The Value of Dual Time Point Imaging. Nuclear Medicine and Molecular Imaging. 43(6). 543–556.
18.
Han, Sehwan, Je Ryong Kim, Jinsun Lee, et al.. (2009). Comparison of 6 cycles versus 4 cycles of neoadjuvant epirubicin plus docetaxel chemotherapy in stages II and III breast cancer. European Journal of Surgical Oncology. 35(6). 583–587. 10 indexed citations
19.
Lee, Chang‐Min, Dae‐Young Kang, & Je Ryong Kim. (2009). A Comparison of Conventional Thyroidectomy and LVSS Thyroidectomy: The Feasibility of the LVSS in the Thyroid Operation. Journal of the Korean Surgical Society. 76(3). 149–149.
20.
Kim, Je Ryong, et al.. (2000). Prognostic Factors in Breast Cancer Patients Following Neoadjuvant Chemotherapy.. Journal of the Korean Surgical Society. 59(6). 729–737. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mitsuhiro Mizutani Breakdown of academic impact, for papers by Se-Kyung Lee Breakdown of academic impact, for papers by Heqing Yi Breakdown of academic impact, for papers by Syed F. Zafar Breakdown of academic impact, for papers by Jyh-Cherng Yu Breakdown of academic impact, for papers by Laura Ruíz-Cañas Breakdown of academic impact, for papers by Gianmatteo Pagani Breakdown of academic impact, for papers by Giles Davies Breakdown of academic impact, for papers by Jarosław Szefel Breakdown of academic impact, for papers by Chuanbing Shi
Rankless by CCL
2026